GlassScriptPhysician profile
Stephen M Crane
NPI 1225244981
$2,305.52
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,981 · 2020: $324.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $380.52 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $307.66 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $264.98 | 2019-2020 | |
| Allergan, INC. | $250.53 | 2019-2020 | |
| Pfizer INC. | $176.90 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $153.56 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $111.27 | 2019-2020 | |
| Novo Nordisk INC | $108.70 | 2019 | |
| Merck Sharp & Dohme LLC | $73.27 | 2019-2020 | |
| Glaxosmithkline, LLC. | $71.98 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.94 | 2019 | |
| Lilly USA, LLC | $63.68 | 2019-2020 | |
| Astellas Pharma US INC | $63.19 | 2019 | |
| Daiichi Sankyo INC. | $39.22 | 2019 | |
| Sanofi Pasteur INC. | $34.18 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $30.45 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.85 | 2020 | |
| Edwards Lifesciences Corporation | $22.15 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.90 | 2020 | |
| Electronic Waveform Lab, INC. | $18.57 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $18.02 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Crane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.